Evidence map›Paper›PMID 32719120›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

CACNA1S haploinsufficiency confers resistance to New World arenavirus infection.

Nicolás Sarute, Susan R Ross

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Fatty acid 2-hydroxylase facilitates rotavirus uncoating and endosomal escape.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Entry inhibitors as arenavirus antivirals.Frontiers in microbiology · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. CACNA1S haploinsufficiency confers resistance to New World arenavirus infection.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nicolás SaruteDepartment of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL 60612.ORCID 0000-0001-6432-1880
Susan R RossDepartment of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL 60612 srross@uic.edu.ORCID 0000-0002-3094-3769

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ROTHMAN, RICHARD E · 2003 to 2013
$91.5M
TRIM2, a novel host factor that restricts New World Arenavirus infectionR21AI112696 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROSS, SUSAN R · 2014 to 2015
$440k
NIAID NIH HHS R21 AI112696NIAID NIH HHS U54 AI057168
6 · The paper itself

Abstract

Understanding the genetics of susceptibility to infectious agents is of great importance to our ability to combat disease. Here, we show that voltage-gated calcium channels (VGCCs) are critical for cellular binding and entry of the New World arenaviruses Junín and Tacaribe virus, suggesting that zoonosis via these receptors could occur. Moreover, we demonstrate that α1s haploinsufficiency renders cells and mice more resistant to infection by these viruses. In addition to being more resistant to infection, haploinsufficient cells and mice required a lower dosage of VGCC antagonists to block infection. These studies underscore the importance of genetic variation in susceptibility to both viruses and pharmaceutics.

Indexed as

AnimalsArenaviridae InfectionsArenaviruses, New WorldCalcium Channel AgonistsCalcium Channel BlockersCalcium Channels, L-TypeCells, CulturedDisease ResistanceDose-Response Relationship, DrugHeterozygoteHumansMiceMice, Mutant StrainsMutationVirus AttachmentVirus InternalizationCalcium Channel AgonistsCalcium Channel BlockersCalcium Channels, L-Typearenavirusgabapentinpharmacogeneticsreceptorvoltage-gated calcium channel

Identifiers

PMID32719120
PMCPMC7431027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.